Biosimilars 2022 Year in Review

This event has ended.


Since the passage of the Biologics Price Competition and Innovation Act (BPCIA), the field of biosimilars has expanded and evolved. Keeping abreast of these changes helps stakeholders understand future opportunities.

In this webinar, life sciences attorneys Geoff Biegler and Jenny Shmuel will provide a comprehensive look at the U.S. biosimilars field in 2022. The webinar will cover:

  • The U.S. biosimilars market, including approvals and launches
  • Legislative and regulatory developments
  • Litigation and post-grant trends

Additionally, our hosts will discuss other developments they anticipate in the biosimilars space in the coming year.

We encourage you to read our Biosimilars 2022 Year in Review blog and share with your colleagues.

If you have any questions, please contact eventsteam@fr.com.